Japanese Healthtech Stock News

Software Service (TSE:3733) has put up another solid quarter, with Q2 2026 revenue at ¥14.9 billion and basic EPS of ¥364.38, backed by trailing 12 month EPS of ¥1,131.23 and net income of ¥5.9 billion on revenue of ¥46.5 billion. Over the last six reported quarters, revenue has ranged from ¥8.6 billion to ¥14.9 billion while quarterly basic EPS has moved between ¥170.77 and ¥382.30, giving you a clear view of how the earnings power has tracked the top line. With a trailing net profit margin...

Setting the scene for Sumitomo Pharma’s recent share performance Sumitomo Pharma (TSE:4506) has seen its share price move in different directions across timeframes, with a gain of 1.6% over the past day and a decline of 25.2% over the past 3 months. See our latest analysis for Sumitomo Pharma. At a share price of ¥1,437.0, the stock has recently fallen over shorter periods, with the 30 day share price return down 16.9% and the year to date share price return down 41.6%. However, the 1 year...

In late May 2026, Sumitomo Mitsui Banking Corporation and Toshiba Corporation launched two quantum-driven diversified equity indices for Japanese and U.S. stocks, while Sumitomo Mitsui Financial Group reported ongoing progress in its large-scale share repurchase program authorized through July 2026. This combination of advanced quantum optimization for portfolio construction and active capital management highlights Sumitomo Mitsui’s push to integrate cutting-edge technology with balance...

Marui Group (TSE:8252) reported fourth quarter fiscal 2026 results that surpassed earnings expectations, with record operating profit in its FinTech segment supported by higher merchant commission rates and continued SUKI-centric and digital transformation initiatives. See our latest analysis for Marui Group. At a share price of ¥2,734.5, the stock has seen its 1 day share price return rise 1.77%, but its 30 day return is down 8.56% and the year to date share price return is down 15.08%. The...

In early June 2026, Intermedia Intelligent Communications announced the general availability of Cloud Calling for UNIVERGE BLUE, linking KDDI’s nationwide voice services with NEC’s cloud communications platform so Japanese organizations can use KDDI-issued numbers across multiple sites without on-premises voice equipment. This three-way integration between Intermedia, NEC, and KDDI materially eases large-scale migration from NEC’s extensive legacy PBX base to full-cloud communications in...

New 2029 guidance puts long term profitability in focus Mitsubishi Motors (TSE:7211) set out fresh earnings guidance for fiscal 2029, projecting operating profit of ¥160 billion and an operating margin of 4.5%, giving investors a clearer view of its medium term profit targets. See our latest analysis for Mitsubishi Motors. The ¥338.0 share price has seen mixed momentum recently, with a 30 day share price return of 11.40% but a 90 day share price return that declined 11.26%, and a 1 year total...

Tokio Marine Holdings has recently advanced its previously approved share repurchase program, buying back over 16 million shares within its remaining authorization of up to about 48 million shares, as part of its ongoing capital return efforts in 2026. This progress in repurchases underlines management’s emphasis on capital efficiency and shareholder returns, potentially altering how investors view its balance between growth investments and excess capital deployment. We’ll now examine how...

Investor activism puts EXEO Group in focus Oasis Management’s shareholder proposal to appoint Tomoshiro Takemoto as an outside director at EXEO Group (TSE:1951) has pushed governance and board expertise to the forefront ahead of the upcoming AGM. See our latest analysis for EXEO Group. At a share price of ¥2,830.5, EXEO Group has delivered a 7.2% year to date share price return, while its 1 year total shareholder return of 58.0% and 5 year total shareholder return of 148.95% suggest strong...

Board approved buyback puts Kawasaki Kisen Kaisha in focus Kawasaki Kisen Kaisha (TSE:9107) has drawn investor attention after its Board approved a share repurchase program of up to 44,429,000 shares, or 6.96% of share capital, with repurchased shares set for cancellation. See our latest analysis for Kawasaki Kisen Kaisha. The buyback decision comes after a period of strong market interest in Kawasaki Kisen Kaisha, with a 24.06% year to date share price return and a 1 year total shareholder...

In recent months, Kioxia Holdings has rapidly emerged as one of Japan’s most valuable companies as investors focus on its role supplying memory chips and SSDs for AI data centers and enterprise infrastructure. This shift highlights how Japan’s equity market is increasingly anchored by AI-related semiconductor and infrastructure names rather than its traditional manufacturing leaders. With this backdrop, we’ll explore how Kioxia’s push into AI-focused infrastructure and enterprise storage...

If you are wondering whether Mitsubishi UFJ Financial Group at ¥3,219 is still reasonably priced after a strong run, the key question is how that share price lines up against its underlying value. The stock has returned 7.3% over the past week, 15.0% over the last month and 26.5% year to date, with a 69.6% return over the past year and a very large gain over five years. These moves sit against a backdrop of ongoing interest in large Japanese banks, with investors tracking how major lenders...

Soft earnings didn't appear to concern Arigatou Services Company, Limited's ( TSE:3177 ) shareholders over the last...

Natoco Co., Ltd. ( TSE:4627 ) recently posted some strong earnings, and the market responded positively. We have done...

As you might know, Honda Motor Co., Ltd. ( TSE:7267 ) recently reported its yearly numbers. The results don't look...

Sumitomo Realty & Development has recently continued to report negative results for a fifth consecutive quarter, even as the broader Nikkei 225 index has moved higher, underscoring ongoing financial pressures relative to the wider market. This persistent run of weak earnings against a rising benchmark highlights how company‑specific challenges can diverge sharply from broader sector and index trends. We will now examine how this prolonged period of negative results shapes Sumitomo Realty &...

Mitsubishi Electric (TSE:6503) plans to launch its 5th generation silicon carbide MOSFETs for electric vehicle drive systems, targeting higher efficiency and smaller components. The company has opened "Serendie Street Boston," its first US based digital transformation hub, focused on connecting research, startups, and industry partners. Mitsubishi Electric enters this phase of product and business development with its shares at ¥6,014.0. The stock is up 25.6% year to date and 108.5% over...

Subaru of America reported a surge in U.S. vehicle sales in May. Hybrid and electric models reached a record share of the sales mix, accounting for nearly 25% of deliveries. The figures highlight progress in Subaru's electrification push in a key export market for TSE:7270. For investors tracking TSE:7270, the stronger May showing in the U.S. puts a spotlight on Subaru's mix of all wheel drive vehicles and its growing electrified lineup. The auto sector has been steadily rolling out more...

Panasonic Holdings (TSE:6752) expanded its air quality portfolio with the BalancedHome 210 ERV from Panasonic Eco Systems North America, aimed at residential and light commercial projects. Panasonic Avionics Corporation launched its Astrova in-flight engagement solution on Saudia's Airbus A321XLR, marking the first use of its modular platform and advanced mapping technology in Saudi Arabia. For readers tracking TSE:6752, these product launches illustrate how Panasonic is focusing on...

Shionogi (TSE:4507) has received U.S. FDA approval for XOCOVA (ensitrelvir) as the first oral antiviral for post exposure prophylaxis of COVID-19. The company also secured regulatory approval in China for Naldemedine Tosilate to treat opioid induced constipation. These approvals expand Shionogi's marketed portfolio across infectious disease and pain management related conditions. For investors tracking Shionogi at a share price of ¥2,855.0, these dual approvals arrive after a mixed shorter...

Q1 2027 headline numbers and earnings setup Sekisui House (TSE:1928) opened fiscal 2027 with Q1 revenue of ¥908.9 billion and basic EPS of ¥90.21, setting the tone for how the year may shape up after a strong run into the end of 2026. Over the last few reported quarters, revenue has ranged from ¥894.0 billion in Q1 2026 to ¥1.3 trillion in Q4 2026, while basic EPS moved between ¥51.49 and ¥131.17 over the same period, giving you a clear sense of how the top and bottom line have tracked...

IHI (TSE:7013) is back in focus after its subsidiary, IHI Aerospace, received a five month suspension from bidding on Japan Aerospace Exploration Agency contracts following improper cost claims. This development has put a spotlight on compliance risks and visibility of future aerospace orders. See our latest analysis for IHI. Against this backdrop, IHI’s share price has been under pressure in recent weeks, with a 30 day share price return of down 11.7% and a 90 day share price return of down...

AI-fueled rally puts Kioxia in the spotlight Kioxia Holdings (TSE:285A) is in focus after a powerful rally tied to enthusiasm for its memory chips used in AI data centers briefly lifted its market value above Toyota Motor. See our latest analysis for Kioxia Holdings. At a share price of ¥76,940, Kioxia has seen very strong momentum, with a 30 day share price return of 111.32%, a 90 day share price return of 285.18%, and a year to date share price return of 577.89%. The 1 year total...

Tess Holdings Co.,Ltd. ( TSE:5074 ), might not be a large cap stock, but it received a lot of attention from a...

Luminopia, Inc. recently announced an exclusive licensing agreement granting Rohto Pharmaceutical Co., Ltd. rights to develop and commercialize its digital therapy for pediatric amblyopia in Japan, with Rohto leading local clinical and regulatory efforts. This collaboration gives Rohto a new entry point into prescription-grade digital health therapies, broadening its traditional eye-care portfolio into software-based treatments. Next, we will examine how this move into digital pediatric eye...